https://www.selleckchem.com/pr....oducts/leptomycinb.h
35 [95% CI=0.96-1.91]) but a marked increased risk during the final 4-10 years of follow-up (HR=3.28 [95% CI=2.25-4.77]). Non-operated patients with obesity had a marked excess risk of heart failure throughout the study period compared with population controls. Gastric bypass for obesity seems to reduce the risk of heart failure to levels similar to the general population during the initial 4years after surgery, but not thereafter. Gastric bypass for obesity seems to reduce the risk of heart failure to levels similar to the gene
Aimer
Commentaire
Partagez
